These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 1700544)
1. Expression of enzymatically active reverse transcriptase of simian immunodeficiency virus in bacteria: sensitivity to nucleotide analogue inhibitors. Prasad VR; Myrick K; Haseltine W; Goff SP Virology; 1990 Dec; 179(2):896-900. PubMed ID: 1700544 [TBL] [Abstract][Full Text] [Related]
2. Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate. Vrang L; Oberg B; Löwer J; Kurth R Antimicrob Agents Chemother; 1988 Nov; 32(11):1733-4. PubMed ID: 2472774 [TBL] [Abstract][Full Text] [Related]
3. Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate. Reardon JE; Miller WH J Biol Chem; 1990 Nov; 265(33):20302-7. PubMed ID: 1700787 [TBL] [Abstract][Full Text] [Related]
4. Kinetics and inhibition of reverse transcriptase from human and simian immunodeficiency viruses. Wu JC; Chernow M; Boehme RE; Suttmann RT; McRoberts MJ; Prisbe EJ; Matthews TR; Marx PA; Chuang RY; Chen MS Antimicrob Agents Chemother; 1988 Dec; 32(12):1887-90. PubMed ID: 2469388 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate. Tan CK; Civil R; Mian AM; So AG; Downey KM Biochemistry; 1991 May; 30(20):4831-5. PubMed ID: 1709809 [TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 reverse transcriptase. 3'-Azidodeoxythymidine 5'-triphosphate inhibition indicates two-step binding for template-primer. Jaju M; Beard WA; Wilson SH J Biol Chem; 1995 Apr; 270(17):9740-7. PubMed ID: 7537269 [TBL] [Abstract][Full Text] [Related]
7. AZT resistance of simian foamy virus reverse transcriptase is based on the excision of AZTMP in the presence of ATP. Hartl MJ; Kretzschmar B; Frohn A; Nowrouzi A; Rethwilm A; Wöhrl BM Nucleic Acids Res; 2008 Feb; 36(3):1009-16. PubMed ID: 18096624 [TBL] [Abstract][Full Text] [Related]
8. Reverse transcriptase-like activity in Trypanosoma cruzi. González CI; Thomas MC; Martín F; Alcami J; Alonso C; López MC Acta Trop; 1997 Feb; 63(2-3):117-26. PubMed ID: 9088425 [TBL] [Abstract][Full Text] [Related]
9. The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template. Ma QF; Bathurst IC; Barr PJ; Kenyon GL Biochemistry; 1992 Feb; 31(5):1375-9. PubMed ID: 1371070 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase. Fan N; Rank KB; Poppe SM; Tarpley WG; Sharma SK Biochemistry; 1996 Feb; 35(6):1911-7. PubMed ID: 8639674 [TBL] [Abstract][Full Text] [Related]
11. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases. Amacker M; Hübscher U J Mol Biol; 1998 May; 278(4):757-65. PubMed ID: 9614940 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human immunodeficiency virus type 1 reverse transcriptase is heterogeneous. Wilson JE; Wright LL; Martin JL; Haire SE; Ray PH; Painter GR; Furman PA J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jan; 11(1):20-30. PubMed ID: 8528729 [TBL] [Abstract][Full Text] [Related]
13. 3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase. St Clair MH; Richards CA; Spector T; Weinhold KJ; Miller WH; Langlois AJ; Furman PA Antimicrob Agents Chemother; 1987 Dec; 31(12):1972-7. PubMed ID: 2449866 [TBL] [Abstract][Full Text] [Related]
14. Simian immunodeficiency virus reverse transcriptase. Purification and partial characterization. Kraus G; Behr E; Baier M; König H; Kurth R Eur J Biochem; 1990 Aug; 192(1):207-13. PubMed ID: 1698157 [TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus reverse transcriptase: steady-state and pre-steady-state kinetics of nucleotide incorporation. Reardon JE Biochemistry; 1992 May; 31(18):4473-9. PubMed ID: 1374638 [TBL] [Abstract][Full Text] [Related]
16. Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide. Zhan X; Tan CK; Scott WA; Mian AM; Downey KM; So AG Biochemistry; 1994 Feb; 33(6):1366-72. PubMed ID: 7508746 [TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase. Lowe DM; Parmar V; Kemp SD; Larder BA FEBS Lett; 1991 May; 282(2):231-4. PubMed ID: 1709876 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates. Duan C; Poticha D; Stoeckli TC; Petropoulos CJ; Whitcomb JM; McHenry CS; Kuritzkes DR J Infect Dis; 2001 Nov; 184(10):1336-40. PubMed ID: 11679926 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of the reverse transcriptase from HIV by 3'-azido-3'-deoxythymidine triphosphate and its threo analogue. Vrang L; Bazin H; Remaud G; Chattopadhyaya J; Oberg B Antiviral Res; 1987 Mar; 7(3):139-49. PubMed ID: 2440380 [TBL] [Abstract][Full Text] [Related]
20. Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP. Pokholok DK; Gudima SO; Yesipov DS; Dobrynin VN; Rechinsky VO; Kochetkov SN FEBS Lett; 1993 Jul; 325(3):237-41. PubMed ID: 7686510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]